UPDATE 1-Amgen ends marketing agreement with GSK for osteoporosis drug
April 03, 2014 at 11:41 AM EDT
April 3 (Reuters) - Amgen Inc said it would end an agreement with GlaxoSmithKline Plc for the marketing of its osteoporosis drug in some regions outside the United States.
